| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Bicara Therapeutics Inc. (BCAX) have been net sellers, shedding 58,750 shares worth roughly $1.6M on balance.
BCAX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.60M | $73.65M | - | |
| CEO | 362.2K | $10.13M | - | |
| CEO | 181.6K | $4.26M | - | |
| CFO | 129.9K | $492.1K | - | |
| Other | 55.3K | $1.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Raben David49 | Chief Medical Officer | Sale+OE10b5-1 | 16,500 | $18.52 | $305,610.01 | -23.0% | +5.9% | - | |
| Mar 4, 2026 | Hyep Ivan62 | Chief Financial Officer | Sale+OE10b5-1 | 16,518 | $18.22 | $300,971.46 | -10.2% | +5.9% | - | |
| Mar 3, 2026 | Cohlhepp Ryan52 | President and COO | Sale+OE10b5-1 | 17,392 | $18.16 | $315,892.64 | -7.8% | +15.1% | - | |
| Feb 26, 2026 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 300,000 | $16.00 | $4,800,000.00 | +7.0% | +28.5% | - | |
| Feb 25, 2026 | Cohlhepp Ryan52 | President and COO | Sale+OE10b5-1 | 3,631 | $18.04 | $65,501.42 | -1.7% | +25.5% | - | |
| Jan 22, 2026 | Cohlhepp Ryan52 | President and COO | Sell10b5-1 | 3,828 | $18.10 | $69,295.99 | -1.8% | +34.3% | - | |
| Jan 22, 2026 | Hyep Ivan62 | Chief Financial Officer | Sale+OE10b5-1 | 1,882 | $18.15 | $34,162.44 | -1.3% | +34.3% | - | |
| Jan 15, 2026 | Cohlhepp Ryan52 | President and COO | Sell10b5-1 | 149 | $18.02 | $2,684.98 | - | +42.1% | - | |
| Dec 22, 2025 | Hyep Ivan62 | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $18.31 | $168,491.56 | -6.0% | +0.4% | - | |
| Dec 15, 2025 | Cohlhepp Ryan52 | President and COO | Sale+OE10b5-1 | 12,500 | $18.68 | $233,547.50 | -6.2% | +5.7% | - |